It is generally thought that the oxidative modification of hemoproteins leads to their inactivation. In the current study, however, a transiently activated form of myoglobin was shown to be formed when the prosthetic heme group became covalently bound to the polypeptide during the reaction of myoglobin with low levels of HOOH. In the presence of an enzymatic metmyoglobin reducing system containing diaphorase and methylene blue with excess NADH, this HOOHaltered myoglobin catalyzed NADH oxidation and oxygen consumption; the overall stoichiometry indicated a twoelectron reduction of oxygen to HOOH. This reaction was not catalyzed by iron released from heme, as desferrioxamine had no effect on the activity. Stoichiometric amounts of HOOH were sufficient to produce the activated oxidase state of myoglobin, whereas larger amounts of HOOH lead to heme destruction, iron release, and inactivation of the oxidase activity.The alteration of myoglobin to an enzyme that can form toxic oxygen metabolites may have pathological importance, especially in myocardial injury caused by ischemia and reperfusion, where myoglobin is present in large amounts and HOOH is formed. Furthermore, the oxidase form may be involved in the mechanism of destruction of the heme seen with oxidative treatment of myoglobin.Oxidative modification by HOOH or lipid peroxides has been shown to inactivate various hemoproteins, including myoglobin (1-3), hemoglobin (1, 4), cytochrome P450 (5-8), prostaglandin H synthase (9, 10), catalase (11), myeloperoxidase (12), horseradish peroxidase (13), and lactoperoxidase (14,15). The mechanism by which this occurs is unknown, although it is generally thought to involve destruction of the heme moiety (1-8, 10, 14-19).We report, however, that treatment of myoglobin with 1-2.5 equivalents of HOOH results in crosslinking of an intact heme moiety to the protein and gives rise to an altered hemoprotein with oxidase activity. Inactivation occurs only when larger amounts of HOOH, which lead to multiple catalytic events, are used to treat myoglobin.MATERIALS AND METHODS Materials. Diaphorase was purchased from Sigma. Catalase was obtained from Fluka. Superoxide dismutase and NADH were purchased from Calbiochem. HOOH and methylene blue were from Fisher Scientific. Desferrioxamine mesylate was from Ciba. Sperm whale and horse heart myoglobin were obtained from United States Biochemical.Formation of Heme-Derived Adducts from the Reaction of HOOH with Myoglobin. In a previous study (20) on characterization of the protein-bound heme adduct, myoglobin was treated with HOOH at pH 4.7 or 7.4. We have found that HOOH treatment at either pH gives an altered myoglobin with oxidase activity. In this study only acidic conditions were used because these conditions more closely represent the environment of the myocardium under ischemia (21).Specifically, myoglobin (130 AM) was treated with HOOH (330 AM) in a total volume of 2.0 ml of 25 mM sodium acetate, pH 4.7, for 60 min at room temperature. The reaction mixture was placed on i...